Worth at least double.

I just bought more today because under the proposed capital restructuring, my valuation indicates that both SRS and PXUPA are undervalued by at least half.

Using rudimentary asset valuation, my valuation for SRS is as follows:

NCAV = $0.064
NTA = $0.071

Using those values for the conversion ratio for PXUPA would yield a relatively similar undervaluation at current prices.

I would say recent shareholders and PXUPA holders should be in favour of the proposed restructuring as it should unlock value as long as the market reacts rationally.

Please do your own research. Nothing is ever a sure thing!

Here's hoping the market acts rationally as they did when I made my bet with ASL at $0.30.

Also the swing back into operating profits is a nice bonus too.